PULSE BIOSCIENCES, INC. - 8-K Filing

Pulse Biosciences announced its intent to redeem the remaining common stock warrants (200% Warrants) issued in July 2024 as part of a rights offering. The redemption is triggered by meeting the condition that the volume weighted average price exceeded $22.00 per share for 20 consecutive trading days, with an average VWAP of $25.17 during this period. Holders may exercise these warrants until July 13, 2026; unexercised warrants will be redeemed at $0.01 per warrant. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $PLSE

Read the full article at SEC EDGAR

More Regulatory news